Browser does not support script.
All academic staff, visiting staff and PhD students from the Department of Health Policy can contribute to the working paper series.
To be included in the series, please send manuscripts to Lucy Thompson (Communications Manager) along with an abstract of 150-200 words and up to six keywords. The Working Paper editorial team will endeavour to process your submission within three weeks.
WP46 The Blow of Domestic Violence on Children's Health Outcomes Mireia Jofre-Bonet, Melcior Rossello-Roig and Victoria Serra-Sastre
WP45 A Comparative Analysis of the Regulatory Requirements of Orphan Medicinal Products in the United States and European Union Emilie Taymor and Panos Kanavos
WP44 Comparisons of Health Technology Assessment Appraisal Outcomes and Methodologies in Oncology Indications across Four Countries Nick Petersdorf and Panos Kanavos
WP43 Health Technology Assessment of Cancer Drugs in France and Germany - Commonalities and Differences in the Value Assessment of Medical Technologies Anna Szerb and Panos Kanavos
WP42 An analysis of HTA decisions for orphan drugs in Canada and Australia Caroline Solon and Panos Kanavos
WP41 Treating schizophrenia during pregnancy: A systematic literature review on the impact of drug treatment on mother and foetus Mari Grepstad, Victoria Tzouma, Federico Grimaccia and Panos Kanavos
WP40 Treating rheumatoid arthritis during pregnancy: A systematic literature review of the impact of drug treatment on mother and foetus Victoria Tzouma, Mari Grepstad and Panos Kanavos
WP39 Treating epilepsy during pregnancy: a systematic literature review of the impact of drug treatment on mother and foetus Federico Grimaccia and Panos Kanavos
WP38 Assessing Long-Term Care Partnerships: An Old Concept to Redefine? Savannah Bergquist, Joan Costa-Font and Katherine Swartz
WP37 Long Term Care Coverage in Europe: A Case for 'Implicit Insurance Partnerships' Joan Costa-i-Font and Valentina Zigante
WP36 Policy Dilemmas in Financing Long-term Care in Europe Joan Costa-i-Font, Christophe Courbage and Peter Zweifel
WP35 Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines? Divya Srivastava and Alistair McGuire
WP34 Using MCDA to assess value of new medical technologies Aris Angelis and Panos Kanavos
WP33 Multiple Criteria Decision Analysis for Value Based Assessment of New Medical Technologies: A Conceptual Framework Panos Kanavos and Aris Angelis
WP32 Inequalities in Self-Reported Health: A Meta-Regression Analysis Joan Costa-i-Font and Cristina Hernández-Quevedo
WP31 Globesity: Is Globalization a Pathway to Obesity? Joan Costa-i-Font, Núria Mas and Patricia Navarro
WP30 Intergenerational and Socioeconomic Gradients of Child Obesity Joan Costa-i-Font and Joan Gil
WP29 Do Income Gradients in Unhealthy Behaviours Explain Patterns of Health Inequalities? Joan Costa-i-Font, Cristina Hernández-Quevedo and Dolores Jiménez-Rubio
WP28 The hedonic placebo effect of traditional medicines Azusa Sato and Joan Costa-i-Font
WP27 Does culture matter at all in explaining why people still use traditional medicines? Azusa Sato and Joan Costa-i-Font
WP26 Are Health Care 'Choice - and - Competition' Reforms really Efficiency Driven? Joan Costa-i-Font and Valentina Zigante
WP25 Publication Selection in Health Policy Research: the Winner's Curse Hypothesis Joan Costa-i-Font, Alistair McGuire and Tom Stanley
WP24 Pathways towards chronic-care focused healthcare systems: evidence from Spain Manuel García-Goñi, Cristina Hernández-Quevedo, Roberto Nuño-Solinís and Francesco Paolucci
WP23 Demand and Pricing of Preventative Health Care Sotiris Vandoros and Katherine Grace Carman
WP22 Using a Vector Autoregression Framework to measure the quality of English NHS hospitals Irene Papanicolas and Alistair McGuire
WP21 Using a latent variable approach to measure the quality of English NHS hospitals Irene Papanicolas and Alistair McGuire
WP20 Persistence despite Action? Measuring the Patterns of Health Inequality in England (1997-2007) Joan Costa-i-Font, Cristina Hernádez-Quevedo and Alistair McGuire
WP19 Do International Launch Strategies of Pharmaceutical Corporations Respond to Changes in the Regulatory Environment Nebibe Varol, Joan Costa-i-Font and Alistair McGuire
WP18 Medicine prices, availability and affordability in Southern Brazil: a study of public and private facilities Andréa Dâmaso Bertoldi, Ana Paula Helfer, Aline L Camargo, Noêmia UL Tavares and Panos Kanavos
WP17 Technology diffusion and health care productivity: angioplasty in the UK Alistair McGuire, Maria Raikou, Frank Windmeijer and Victoria Serra-Sastre
WP16 Does Hospital Competition Save Lives? Evidence From The Recent English NHS Choice Reforms Zack Cooper, Stephen Gibbons, Simon Jones and Alistair McGuire
WP15 Body Image, Peer Effects and Food Disorders: Evidence from a Sample of European Women Joan Costa-i-Font and Mireia Jofre-Bonet
WP14 An explorative study of "preferred" health care decision rules Adam Oliver
WP13 Parametric estimation of medical care costs under conditions of censoring Maria Raikou and Alistair McGuire
WP12 Decomposing cross-country differences in levels of obesity and overweight: does the social environment matter? Joan Costa-i-Font, Daniele Fabbri and Joan Gil
WP11 Reflections on the Development of Health Inequalities Policy in the United Kingdom Adam Oliver
WP10Conflict in the Doctor-Patient relation and Non-Adherence: A game theory approach Charitini Stavropoulou and Dionysius Glycopantis
WP9Exploring the Pathways of Inequality in Health, Access and Financing in Decentralised Spain Joan Costa-i-Font and Joan Gilb
WP8 Gains in QALYs vs DALYs averted: the troubling implications of using residual life expectancy Mara Airoldi
WP6 Medicines parallel trade in the European Union: a gravity specification Joan Costa-i-Font and Panos Kanavos
WP5 Inferring the Value of Medical Research to the UK Alistair McGuire and Maria Raikou
WP4 Regulating private health insurance in the European Union: the implications of single market legislation and competition policy Sarah Thomson and Elias Mossialos
WP3 Equity in the use of health services in Canada and its provinces Sara Allin
WP2 A conceptual framework for community-based health insurance in low-income countries: social capital and economic development Philipa Mladovsky and Elias Mossialos
WP1 Inequality in health care use among older people in the United Kingdom: an analysis of panel data Sara Allin, Cristina Masseria and Elias Mossialos
For more information about the series, contact the LSE Health Policy communications team.
Share
Learn more about current LSE Health projects
Get recent updates from LSE Health
Our COVID-19 research and response
+ 44 (0) 20 7955 6840
lse_health@lse.ac.uk
LSE Health, Cowdray House, London School of Economics and Political Science, Houghton Street, London WC2A 2AE